Literature DB >> 15161056

Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart.

Nuray Erin1, Philip J Boyer, Robert H Bonneau, Gary A Clawson, Danny R Welch.   

Abstract

Capsaicin specifically activates or destroys small diameter nociceptive sensory neurons that contain the capsaicin receptor, also called vanilloid receptor 1. Neurons sensitive to capsaicin mediate inflammatory pain and are important targets for management of chronic pain. These neurons also regulate local tissue homeostasis, inflammation, healing and development, especially under conditions of psychological stress. Stress contributes to increased cancer recurrence and metastasis through as yet undefined mechanisms. Likewise, activity of capsaicin-sensitive neurons is altered by pathological conditions that may lead to metastatic growth (e.g. stress). Therefore, we examined effects of a treatment that induces sensory nerve denervation on breast cancer metastases. Systemic denervation of sensory neurons caused by treatment with 125 mg/kg capsaicin resulted in significantly more lung and cardiac metastases in adult mice injected orthotopically with syngeneic 4T1 mammary carcinoma cells than was observed in vehicle-treated controls. Heart metastases, normally very rare, occurred as pericardial nodules, intra-myocardial nodules, or combined pericardial-myocardial lesions. Since the rate of primary tumor growth was unaffected, effects on metastases appear to be host tissue-specific. Although preliminary, these observations provide one possible explanation for resistance of cardiac tissue to tumor involvement and highlight contributions of host tissue, including sensory neurons, in the efficiency of cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161056

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

1.  Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.

Authors:  N Erin; A Podnos; G Tanriover; Ö Duymuş; E Cote; I Khatri; R M Gorczynski
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 2.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

3.  Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.

Authors:  Sayra Dilmac; Nuray Erin; Necdet Demir; Gamze Tanriover
Journal:  Pathol Oncol Res       Date:  2017-08-25       Impact factor: 3.201

4.  Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.

Authors:  Nuray Erin; Tümay İpekçi; Bahar Akkaya; İrem Hicran Özbudak; Mehmet Baykara
Journal:  Cancer Microenviron       Date:  2016-10-19

Review 5.  Protective Role of Capsaicin in Neurological Disorders: An Overview.

Authors:  Sakshi Tyagi; Nikhila Shekhar; Ajit Kumar Thakur
Journal:  Neurochem Res       Date:  2022-02-12       Impact factor: 3.996

6.  Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers.

Authors:  John D Hurley; Austin T Akers; Jamie R Friedman; Nicholas A Nolan; Kathleen C Brown; Piyali Dasgupta
Journal:  Cell Adh Migr       Date:  2016-05-19       Impact factor: 3.405

Review 7.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 8.  Nerves in cancer.

Authors:  Ali H Zahalka; Paul S Frenette
Journal:  Nat Rev Cancer       Date:  2020-01-23       Impact factor: 60.716

Review 9.  Role of the parasympathetic nervous system in cancer initiation and progression.

Authors:  M Tibensky; B Mravec
Journal:  Clin Transl Oncol       Date:  2020-08-08       Impact factor: 3.405

10.  HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.

Authors:  Şule Kale; Aylin F Korcum; Ertuğrul Dündar; Nuray Erin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-14       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.